South Korea HPV Testing Market Size, Share, and COVID-19 Impact Analysis, By Test Type (Pap Smear Test, HPV DNA Test, Visual Inspection with Acetic Acid (VIA)), By Application (Cervical Cancer Screening, Vaginal Cancer Screening, Anal Cancer Screening, and Others), and South Korea HPV Testing Market Insights, Industry Trend, Forecasts to 2035

South Korea HPV Testing Market Size Insights Forecasts to 2035

• The South Korea HPV Testing Market size is Expected to Grow at a CAGR of around 9.4% from 2025 to 2035
• The South Korea HPV Testing Market size is expected to hold a significant Share by 2035

According to a Research Report Published by Spherical Insights & Consulting, the South Korea HPV Testing Market Size is anticipated to grow at a CAGR of 9.4% from 2025 to 2035. The market is driven by expanding national cervical cancer screening uptake, shifts toward primary HPV testing over conventional cytology, and the introduction of high-risk HPV genotyping that improves clinical triage and follow-up pathways. Broader reimbursement support and hospital–lab networks are further accelerating adoption.

Market Overview

The South Korea HPV testing market refers to the diagnostic sector that deals with the identification of human papillomavirus (HPV), mainly high-risk types associated with cervical cancer, through molecular tests (DNA test or mRNA tests). The market is expected to grow as HPV testing is increasingly being used instead of traditional cytology testing due to its higher sensitivity and earlier detection of lesions. There is also increased usage of HPV diagnostic testing due to government led cervical cancer screening programs and educational and awareness initiatives focusing on women's health leading to further usage among hospitals and diagnostic laboratories. Also, technological advances, specifically the rise of high risk genotyping, automation and integration with digital pathology, has driven a strong increase in the segment. Post-COVID recovery and improvements in screening volumes has created additional momentum in the poultry market. Conversely, cost sensitivity, reimbursement constraints and limited awareness of self-sampling options continues to restrict uptake.

Report Coverage

This research report categorizes the market for the South Korea HPV testing market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea HPV testing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea HPV testing market.

Driving Factors

The market is driven by increasing number of government-funded cervical cancer screening programs, increased awareness around women’s health, and transition away from cytology to more sensitive molecular HPV testing. Improvements in automation, high-risk HPV genotyping, and integration with digital laboratories have increased efficiency as hospitals and diagnostic laboratories work more closely together to promote the uptake of HPV testing.

Restraining Factors

The South Korea HPV testing market is constrained by high testing costs, lack of reimbursement for testing and price competition on public tenders. Additionally, limited awareness of self-sampling and a slow transition from traditional cytology-based screening stands in the way of widespread acceptance across clinical settings.

Market Segmentation

The South Korea HPV Testing Market share is classified into test type and application.

• The HPV DNA test segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea HPV testing market is segmented by test type into Pap smear test, HPV DNA test, and visual inspection with acetic acid (VIA). Among these, the HPV DNA test segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. HPV DNA tests are preferred as their sensitivity and accuracy is typically higher than Pap smears or VIA. Increasing inclusion of HPV DNA tests in national screening guidelines and enhanced genotyping are fuelling growth. Automation for HPV tests aid in expanding access and demand for HPV testing. Rapid test turnaround also contributes to increasing demand for HPV tests.

• The cervical cancer screening segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea HPV testing market is segmented by application into cervical cancer screening, vaginal cancer screening, anal cancer screening, and others. Among these, the cervical cancer screening segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Cervical cancer screening remains the leading application due to established government-led programs and public campaigns. Hospitals and diagnostic labs are considering HPV testing a primary screening method. Rising participation rates continue to bolster this segments market strength.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea HPV testing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Roche Diagnostics
• Hologic Inc.
• Qiagen N.V.
• Becton, Dickinson and Company
• Abbott Laboratories
• Cepheid
• Seegene Inc.
• Fujirebio Diagnostics, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea HPV Testing Market based on the below-mentioned segments:

South Korea HPV Testing Market, By Test Type

• Pap Smear Test
• HPV DNA Test
• Visual Inspection with Acetic Acid (VIA)

South Korea HPV Testing Market, By Application

• Cervical Cancer Screening
• Vaginal Cancer Screening
• Anal Cancer Screening
• Others